Annual Total Liabilities
$6.68 M
-$1.00 M-13.08%
31 December 2023
Summary:
Oncternal Therapeutics annual total liabilities is currently $6.68 million, with the most recent change of -$1.00 million (-13.08%) on 31 December 2023. During the last 3 years, it has risen by +$819.00 thousand (+13.98%). ONCT annual total liabilities is now -96.01% below its all-time high of $167.54 million, reached on 31 December 2003.ONCT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$6.45 M
-$1.65 M-20.38%
30 September 2024
Summary:
Oncternal Therapeutics quarterly total liabilities is currently $6.45 million, with the most recent change of -$1.65 million (-20.38%) on 30 September 2024. Over the past year, it has increased by +$254.00 thousand (+4.10%). ONCT quarterly total liabilities is now -96.15% below its all-time high of $167.54 million, reached on 31 December 2003.ONCT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.1% | +4.1% |
| 3 y3 years | +14.0% | +10.9% |
| 5 y5 years | +28.2% | -6.5% |
ONCT Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.1% | +22.2% | -20.4% | +21.9% |
| 5 y | 5 years | -13.1% | +28.2% | -30.6% | +21.9% |
| alltime | all time | -96.0% | +303.0% | -96.2% | +254.8% |
Oncternal Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.45 M(-20.4%) |
| June 2024 | - | $8.11 M(+30.4%) |
| Mar 2024 | - | $6.21 M(-6.9%) |
| Dec 2023 | $6.68 M(-13.1%) | $6.68 M(+7.7%) |
| Sept 2023 | - | $6.20 M(+10.9%) |
| June 2023 | - | $5.59 M(-3.5%) |
| Mar 2023 | - | $5.79 M(-24.6%) |
| Dec 2022 | $7.68 M(+40.6%) | $7.68 M(+0.7%) |
| Sept 2022 | - | $7.63 M(+1.3%) |
| June 2022 | - | $7.53 M(+42.1%) |
| Mar 2022 | - | $5.29 M(-3.1%) |
| Dec 2021 | $5.46 M(-6.7%) | $5.46 M(-6.1%) |
| Sept 2021 | - | $5.82 M(-1.4%) |
| June 2021 | - | $5.90 M(+2.5%) |
| Mar 2021 | - | $5.75 M(-1.8%) |
| Dec 2020 | $5.86 M(-21.2%) | $5.86 M(-25.4%) |
| Sept 2020 | - | $7.85 M(-15.6%) |
| June 2020 | - | $9.30 M(+26.2%) |
| Mar 2020 | - | $7.37 M(-0.8%) |
| Dec 2019 | $7.43 M(+42.6%) | $7.43 M(+7.7%) |
| Sept 2019 | - | $6.90 M(-13.4%) |
| June 2019 | - | $7.97 M(+338.0%) |
| Mar 2019 | - | $1.82 M(-65.1%) |
| Dec 2018 | $5.21 M(-34.7%) | $5.21 M(-44.0%) |
| Sept 2018 | - | $9.30 M(+18.1%) |
| June 2018 | - | $7.88 M(-18.0%) |
| Mar 2018 | - | $9.61 M(+20.5%) |
| Dec 2017 | $7.97 M(+73.0%) | $7.97 M(-14.1%) |
| Sept 2017 | - | $9.28 M(+79.0%) |
| June 2017 | - | $5.18 M(+9.0%) |
| Mar 2017 | - | $4.76 M(+3.2%) |
| Dec 2016 | $4.61 M(-84.7%) | $4.61 M(+37.1%) |
| Sept 2016 | - | $3.36 M(-4.7%) |
| June 2016 | - | $3.53 M(+16.9%) |
| Mar 2016 | - | $3.02 M(-90.0%) |
| Dec 2015 | $30.17 M(-8.1%) | $30.17 M(-9.8%) |
| Sept 2015 | - | $33.47 M(-54.3%) |
| June 2015 | - | $73.17 M(+144.8%) |
| Mar 2015 | - | $29.89 M(-8.9%) |
| Dec 2014 | $32.82 M(+567.0%) | $32.82 M(+1267.6%) |
| Sept 2014 | - | $2.40 M(-37.7%) |
| June 2014 | - | $3.85 M(-18.2%) |
| Mar 2014 | - | $4.71 M(-4.3%) |
| Dec 2013 | $4.92 M | $4.92 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | - | $5.55 M(-36.4%) |
| June 2013 | - | $8.73 M(+1.1%) |
| Mar 2013 | - | $8.64 M(-14.3%) |
| Dec 2012 | $10.07 M(+48.5%) | $10.07 M(-17.9%) |
| Sept 2012 | - | $12.26 M(+64.5%) |
| June 2012 | - | $7.46 M(+27.6%) |
| Mar 2012 | - | $5.84 M(-13.8%) |
| Dec 2011 | $6.78 M(-45.8%) | $6.78 M(+24.8%) |
| Sept 2011 | - | $5.44 M(+6.2%) |
| June 2011 | - | $5.12 M(+47.2%) |
| Mar 2011 | - | $3.48 M(-72.2%) |
| Dec 2010 | $12.52 M(-81.2%) | $12.52 M(-4.4%) |
| Sept 2010 | - | $13.09 M(-8.7%) |
| June 2010 | - | $14.34 M(-7.9%) |
| Mar 2010 | - | $15.56 M(-76.6%) |
| Dec 2009 | $66.47 M(-12.6%) | $66.47 M(+2.2%) |
| Sept 2009 | - | $65.03 M(-4.1%) |
| June 2009 | - | $67.83 M(-4.2%) |
| Mar 2009 | - | $70.83 M(-6.9%) |
| Dec 2008 | $76.09 M(-5.8%) | $76.09 M(+6.5%) |
| Sept 2008 | - | $71.42 M(-4.1%) |
| June 2008 | - | $74.47 M(-6.9%) |
| Mar 2008 | - | $79.99 M(-1.0%) |
| Dec 2007 | $80.81 M(+150.9%) | $80.81 M(+180.8%) |
| Sept 2007 | - | $28.78 M(-8.9%) |
| June 2007 | - | $31.58 M(-1.6%) |
| Mar 2007 | - | $32.08 M(-0.4%) |
| Dec 2006 | $32.21 M(+248.9%) | $32.21 M(-14.9%) |
| Sept 2006 | - | $37.83 M(+298.5%) |
| June 2006 | - | $9.49 M(-11.3%) |
| Mar 2006 | - | $10.71 M(+16.0%) |
| Dec 2005 | $9.23 M(+0.6%) | $9.23 M(-24.3%) |
| Sept 2005 | - | $12.19 M(-2.1%) |
| June 2005 | - | $12.45 M(+17.8%) |
| Mar 2005 | - | $10.57 M(+15.2%) |
| Dec 2004 | $9.17 M(-94.5%) | $9.17 M(+7.0%) |
| Sept 2004 | - | $8.58 M(-9.9%) |
| June 2004 | - | $9.52 M(+0.6%) |
| Mar 2004 | - | $9.47 M(-94.3%) |
| Dec 2003 | $167.54 M(+156.4%) | $167.54 M |
| Dec 2002 | $65.34 M(+47.9%) | - |
| Dec 2001 | $44.19 M(+55.8%) | - |
| Dec 2000 | $28.37 M(+1611.9%) | - |
| Dec 1999 | $1.66 M | - |
FAQ
- What is Oncternal Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual total liabilities year-on-year change?
- What is Oncternal Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly total liabilities year-on-year change?
What is Oncternal Therapeutics annual total liabilities?
The current annual total liabilities of ONCT is $6.68 M
What is the all time high annual total liabilities for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual total liabilities is $167.54 M
What is Oncternal Therapeutics annual total liabilities year-on-year change?
Over the past year, ONCT annual total liabilities has changed by -$1.00 M (-13.08%)
What is Oncternal Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ONCT is $6.45 M
What is the all time high quarterly total liabilities for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly total liabilities is $167.54 M
What is Oncternal Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ONCT quarterly total liabilities has changed by +$254.00 K (+4.10%)